Skip to main content
Equibles

Propel Bio Management, LLC

Position in ABEO — Abeona Therapeutics Inc.

CIK 1969764 LOS ANGELES, CA
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,075,372
+$117,425 QoQ
Shares Held
983,070
-26.1% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
#12
of 125 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 65% Shared 35% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Propel Bio Management, LLC holds $132,912,353 across 24 Biotechnology names. ABEO ranks #7 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACHV
Achieve Life Sciences, Inc.
 4,034,018 $26,342,137
2 CORT
Corcept Therapeutics Inc
 136,499 $11,868,588
3 PHAT
Phathom Pharmaceuticals, Inc.
 1,050,358 $11,396,384
4 MIST
Milestone Pharmaceuticals Inc.
 7,429,590 $9,955,650
5 KYTX
Kyverna Therapeutics, Inc.
 883,198 $7,869,294
6 ARTV
Artiva Biotherapeutics, Inc.
 696,436 $6,755,429
7 ABEO
Abeona Therapeutics Inc.
This page 		983,070 $6,075,372
8 PALI
Palisade Bio, Inc.
 2,582,388 $5,397,190

All Filings in ABEO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,075,372 983,070
2026-03-31 $5,957,947 1,329,899
2025-12-31 $4,378,210 830,780
2025-09-30 $5,142,836 974,022
2025-06-30 $5,532,444 974,022
2025-03-31 $2,970,344 624,022
2024-12-31 $3,475,802 624,022
2024-09-30 $3,943,819 624,022
2024-06-30 $5,291,706 1,248,044